Burosumab Antibody
Burosumab (KRN23) is a human monoclonal antibody designed to neutralize fibroblast growth factor 23 (FGF23) . It is used in research models of FGF23-related hypophosphatemic disorders, such as X-linked hypophosphatemia and tumor-induced osteomalacia, to study phosphate metabolism and bone mineralization in both in vitro and in vivo experimental settings.
Product Specifications
Product Name Alternative
Burosumab, KRN 23, KRN23, KRN-23
Target
Others
Clonality
Monoclonal
Conjugation
Unconjugated
Concentration
4.55 mg/mL
Purity
97.90% (May vary between batches)
Molecular Weight
144.08 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15138518 1 Vial
Lentiviral human CHN1 shRNA (UAS) - Lentiviral human CHN1 shRNA (UAS, iRFP) (25)
Sign In for Pricing
View Details